Zedira

Transglutaminases are a family of enzymes with a precise biological role: they catalyse the formation of covalent bonds between proteins, a mechanism fundamental to processes ranging from blood coagulation and cell biology to inflammation and tissue development. Understanding — and modulating — this enzyme family has become increasingly relevant for pharmaceutical research and diagnostic tool development, particularly in connection with conditions such as coeliac disease, certain neurodegenerative disorders, and chronic inflammation-related pathologies. Zedira has built a specialised portfolio of transglutaminase-related products — inhibitors, substrates, antibodies, diagnostic kits — designed to serve both the academic world and industry. The proposition is one of vertical expertise and reliability: not a generalist reagent supplier, but a specialist with deep knowledge of transglutaminase biology who offers products developed specifically for the needs of those working in this field. The target customers include pharmaceutical and biotech companies developing therapies or diagnostic tools related to transglutaminases, academic researchers, and clinical institutes studying associated pathologies. The B2B model is built around tailored solutions and services that can be adapted to the specific requirements of each project. In a highly specialised market segment, Zedira occupies a niche position with deep domain knowledge — precisely the kind of partner that advanced research needs when generalist expertise is not enough.